financetom
Market
financetom
/
Market
/
Primerica Q3 adjusted EPS beat estimates on higher premiums 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Primerica Q3 adjusted EPS beat estimates on higher premiums 
Nov 5, 2025 3:01 PM

Overview

* Primerica ( PRI ) Q3 adjusted revenue and EPS beat analyst expectations

* Record ISP sales of $3.7 bln, up 28% yr/yr

* Company repurchased $129 mln of common stock during the quarter

Outlook

* Company did not provide specific guidance for future quarters or full year in the statement

Result Drivers

* ISP SALES GROWTH - Record ISP sales of $3.7 bln, up 28% yr/yr, driven by strong demand and favorable equity markets

* TERM LIFE PREMIUMS - Term Life net premiums increased 3% with adjusted direct premiums growing 5%, despite a 15% decline in new policies issued

* ACTUARIAL ASSUMPTION REVIEW - Annual actuarial assumption review resulted in a net remeasurement gain of $23.1 mln, impacting earnings positively

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $838.90 $825.39

Adjusted mln mln (5

Revenue Analysts

)

Q3 Beat $6.33 $5.54 (9

Adjusted Analysts

EPS )

Q3 EPS $6.35

Q3 Net $206.80

Income mln

Q3 $206.10

Adjusted mln

operatin

g income

Q3 ROE 35.90%

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the life & health insurance peer group is "buy."

* Wall Street's median 12-month price target for Primerica Inc ( PRI ) is $320.00, about 18.6% above its November 4 closing price of $260.41

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exchange-Traded Funds Rise as US Equities Trade Mixed After Midday
Exchange-Traded Funds Rise as US Equities Trade Mixed After Midday
Nov 11, 2025
01:07 PM EST, 11/11/2025 (MT Newswires) -- Broad Market Indicators Broad-market exchange-traded funds IWM and IVV edged higher. Actively traded Invesco QQQ Trust (QQQ) was down 0.3%. US equity indexes were mixed in midday trading on Tuesday, led by declines in the technology and communication services sectors. Energy iShares US Energy ETF (IYE) and the Energy Select Sector SPDR (XLE)...
Sector Update: Financial
Sector Update: Financial
Nov 11, 2025
01:36 PM EST, 11/11/2025 (MT Newswires) -- Financial stocks were advancing in Tuesday afternoon trading, with the NYSE Financial Index rising 0.8% and the Financial Select Sector SPDR Fund (XLF) up 0.6%. The Philadelphia Housing Index was climbing 1.2%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 1.1%. Bitcoin (BTC-USD) was declining 2.5% to $103,316, and the...
Sector Update: Tech
Sector Update: Tech
Nov 11, 2025
01:06 PM EST, 11/11/2025 (MT Newswires) -- Tech stocks were lower Tuesday afternoon, with the Technology Select Sector SPDR Fund (XLK) decreasing 0.8% and the SPDR S&P Semiconductor ETF (XSD) falling 2.3%. The Philadelphia Semiconductor index declined 1.8%. In corporate news, Nvidia ( NVDA ) shares fell 2.8% after SoftBank said it has sold its entire stake in the chipmaker...
Sector Update: Health Care
Sector Update: Health Care
Nov 11, 2025
01:20 PM EST, 11/11/2025 (MT Newswires) -- Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index adding 2.2% and the Health Care Select Sector SPDR Fund (XLV) advancing 2.1%. The iShares Biotechnology ETF (IBB) climbed 2.5%. In corporate news, Novo Nordisk ( NVO ) has reduced the price of its weight management drug Wegovy by up to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved